【24h】

NCRP HOT TOPICS

机译:NCRP热门话题

获取原文

摘要

Perhaps the hottest National Council on Radiation Protection and Measurements (NCRP) topic is that Dr. Thomas S. Tenforde is the new NCRP president so, as you may know, I am presenting this paper as NCRP President Emeritus with Dr. Tenforde's concurrence. Since the theme of today's program is "Homeland Security," a short summary of the important issues in NCRP Report No. 138, Management of Terrorist Events Involving Radioactive Material, is in order. I understand that this Report and its contents may be discussed later in the conference so I will limit my remarks to a few of my favorite issues. As you are hopefully aware the release of NCRP reports has been and will continue to be prodigious. A listing of those that are expected and those possible for release in 2002 together with a brief discussion will perhaps whet your appetite and demonstrate the wide range of important topics the Council embraces. The last issue deals with a current controversy within the Council; the design criteria for medical installations using x-ray and gamma-ray sources. Many in the medical physics community believe that 1 mSv (100 mrem) y~(-1) is acceptable. However, that criteria belies the requirement for optimization (ALARA) and fails to recognize that an individual member of the public may be exposed to more than one source of exposure. A short review of the development of dose limits for the public will focus attention on the issue.
机译:也许是最热门的国家辐射保护和测量委员会(NCRP)主题是托马斯S. Tenforde博士是新的NCRP总裁所以,正如您所知道的那样,我正在向NCRP总裁Emeritus与Tenforde博士的同意提交。由于今天的计划的主题是“国土安全”,简短摘要NCRP报告第138号的重要问题,涉及放射性物质的恐怖主义事件的管理是有序的。我明白这份报告及其内容可以在稍后在会议上讨论,所以我会将我的言论限制在我最喜欢的一些问题中。正如您希望意识到NCRP报告的发布,并将继续令人惊叹。预期的列表,2002年释放的人员与简要讨论一起展示您的胃口可能会展示安理会拥抱的广泛重要主题。最后一期涉及理事会内的目前争议;使用X射线和伽马射源的医疗装置设计标准。医学物理社区中的许多人认为,1 MSV(100 MREM)Y〜(-1)是可以接受的。但是,该标准允许要求优化(ALARA)并未能认识到公众的个人成员可能会暴露于不止一个暴露源。对公众的剂量限制的开发简短审查将重点关注问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号